Market Overview

From Earlier: Mizuho Securities Downgrades Myriad Genetics, Inc. to Neutral, Lowers PT to $30.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for MYGN

DateFirmActionFromTo
Feb 2017Ladenburg ThalmannUpgradesSellNeutral
Jan 2017Deutsche BankInitiates Coverage OnSell
Nov 2016Stephens & Co.DowngradesOverweightEqual-Weight

View More Analyst Ratings for MYGN
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (MYGN)